» Articles » PMID: 4881068

The Effects of Drugs on Onchocerca Volvulus. 3. Trials of Suramin at Different Dosages and a Comparison of the Brands Antrypol, Moranyl and Naganol

Overview
Specialty Public Health
Date 1968 Jan 1
PMID 4881068
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Suramin and Mel W are the only two drugs at present known to be effective against the adult worms of Onchocerca volvulus, but in view of the unpredictable occurrence of fatal arsenical encephalopathy in a small proportion of patients receiving Mel W, suramin remains the preferred macrofilaricide in the treatment of onchocerciasis. It is therefore important to determine the suramin dosage schedules that will produce parasitological cures with minimal concomitant risks of toxic reactions. The criteria by which cures should be judged must also be appreciated.Courses of different duration and employing doses of 1.0 g, 0.5 g and 0.25 g suramin have been investigated for their action on adult worms and microfilariae, for the toxic reactions which they produce on the kidney, and for the level of suramin reached in the serum during treatment. A course of 5 or 6 weekly doses of 1.0 g has been shown to be the optimum for adults.It is sometimes stated without good foundation that different brands of suramin differ in their purity and chemical composition, thus producing inconsistent effects on the parasites and grave risks of toxic manifestations. The three main brands in current use in Africa (Antrypol, Moranyl and Naganol) have therefore been compared in a group of patients, using the same optimum dosage schedule for each preparation and recording the action of the various brands on the parasites, as well as their comparative toxicities and the serum suramin levels achieved. No significant differences between the brands were recorded.

Citing Articles

The bumpy road of purinergic inhibitors to clinical application in immune-mediated diseases.

Wyss M, Heuer C, Herwerth M Neural Regen Res. 2023; 19(6):1206-1211.

PMID: 37905866 PMC: 11467927. DOI: 10.4103/1673-5374.386405.


Onchocerciasis drug development: from preclinical models to humans.

Ngwewondo A, Scandale I, Specht S Parasitol Res. 2021; 120(12):3939-3964.

PMID: 34642800 PMC: 8599318. DOI: 10.1007/s00436-021-07307-4.


Repurposing clinical drugs is a promising strategy to discover drugs against Zika virus infection.

Song W, Zhang H, Zhang Y, Li R, Han Y, Lin Y Front Med. 2020; 15(3):404-415.

PMID: 33369711 PMC: 7768800. DOI: 10.1007/s11684-021-0834-9.


Changes in visual function and in the posterior segment of the eye during treatment of onchocerciasis with diethylcarbamazine citrate.

Bird A, Anderson J, Fuglsang H Br J Ophthalmol. 1980; 64(3):191-200.

PMID: 7387952 PMC: 1039386. DOI: 10.1136/bjo.64.3.191.


[Treatment of onchocerciasis in hyperendemic communities in West Africa with small, gradually increasing doses of suramin. 1. Parasitological results and ophthalmological surveillance in a region where transmission has not been interrupted].

Rougemont A, Thylefors B, Ducam M, Prost A, RANQUE P, Delmont J Bull World Health Organ. 1980; 58(6):917-22.

PMID: 6971188 PMC: 2395997.


References
1.
Duke B, Lewis D, Moore P . Onchocerca-Simulium complexes. I. Transmission of forest and Sudan-savanna strains of Onchocerca volvulus, from Cameroon, by Simulium damnosum from various West African bioclimatic zones. Ann Trop Med Parasitol. 1966; 60(3):318-26. View

2.
Duke B . The reappearance, rate of increase and distribution of the microfilariae of Onchocerca volvulus following treatment with diethylcarbamazine. Trans R Soc Trop Med Hyg. 1957; 51(1):37-44. DOI: 10.1016/0035-9203(57)90004-4. View

3.
Gage J, ROSE F, Scott M . The estimation of suramin in plasma. Biochem J. 1948; 42(4):574-7. PMC: 1258781. View

4.
Dangerfield W, Gaunt W, WORMALL A . Studies on Bayer 205 (Germanin) and Antrypol: The determination of small amounts of Bayer 205 (and Antrypol). II. The persistence of Bayer 205 in the blood stream after injection into animals. Biochem J. 1938; 32(1):59-70. PMC: 1263992. DOI: 10.1042/bj0320059. View

5.
Burch T, ASHBURN L . Experimental therapy of onchocerciasis with suramin and hetrazan; results of a three-year study. Am J Trop Med Hyg. 1951; 31(5):617-23. DOI: 10.4269/ajtmh.1951.s1-31.617. View